
    
      All subjects will undergo rest and stress scans. Those subjects who qualify by demonstrating
      at least 1 reversible defect, will undergo a third scan. All stress scans will involve the
      injection of regadenoson as the pharmacologic stress agent. Prior to the third scan, the
      subject will be administered blinded capsules of placebo or caffeine.
    
  